T2D Might Increase Risk of Post Colonoscopy Colorectal Cancer: BMC

Post-colonoscopy colorectal cancer (PCCRC), a term endorsed by the World Endoscopy Organization, refers to colorectal cancers (CRCs) diagnosed after a negative colonoscopy with a prevalence of up to 8% of all colorectal cancers. A recent study suggests that patients with type 2 diabetes (T2D) have an increased relative risk of post-colonoscopy colorectal cancers compared with patients without T2D. The study findings were published in the journal BMJ Open Gastroenterology on December 24, 2021.
Studies have shown that patients with T2D are at particularly high risk of CRC. However, evidence regarding the impact of T2D on the risk of PCCRC is needed to improve the overall colonoscopy quality and to guide clinical decision making, particularly for planning surveillance colonoscopies for patients with T2D within CRC screening programmes. Therefore, Dr Frederikke Schønfeldt Troelsen and his team conducted a study to investigate whether patients with T2D are at increased risk of PCCRC compared with patients without T2D.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.